Hui Wu - Huadong Medicine Deputy Mang

000963 Stock   35.95  0.24  0.66%   

Executive

Hui Wu is Deputy Mang of Huadong Medicine Co
Age 55
Address No. 866 Moganshan Road, Hangzhou, China, 310011
Phone86 571 8990 3388
Webhttps://www.eastchinapharm.com

Huadong Medicine Management Efficiency

The company has return on total asset (ROA) of 0.0671 % which means that it generated a profit of $0.0671 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1478 %, meaning that it generated $0.1478 on every $100 dollars invested by stockholders. Huadong Medicine's management efficiency ratios could be used to measure how well Huadong Medicine manages its routine affairs as well as how well it operates its assets and liabilities. At present, Huadong Medicine's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 1.3 B, whereas Other Current Assets are forecasted to decline to about 56.9 M.

Similar Executives

Showing other executives

EXECUTIVE Age

Yan LiuBank of China
N/A
Lee WooAgricultural Bank of
N/A
Jicheng QiuChina Construction Bank
52
Yan XiongIndustrial and Commercial
60
Zheng ZhongKweichow Moutai Co
53
Wei FangPetroChina Co Ltd
N/A
Jiangtao MscChina Merchants Bank
52
Yuanguo ChengChina Construction Bank
61
Zhe YangBank of China
N/A
Wenjing JiangChina Merchants Bank
N/A
Guoqiang HanAgricultural Bank of
57
Gang WuAgricultural Bank of
59
Xueqing GuanIndustrial and Commercial
61
FCS FCISChina Mobile Limited
N/A
Jiandong LiuBank of China
55
Zou XinIndustrial and Commercial
N/A
Jin HouChina Life Insurance
44
Walter BrandstaetterChina Construction Bank
N/A
Di ZhangChina Life Insurance
56
Chongmiao XuChina Life Insurance
55
Zhao CaiBank of China
51
Huadong Medicine Co (000963) is traded on Shenzhen Stock Exchange in China and employs 16,969 people. Huadong Medicine is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

Huadong Medicine Leadership Team

Elected by the shareholders, the Huadong Medicine's board of directors comprises two types of representatives: Huadong Medicine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Huadong. The board's role is to monitor Huadong Medicine's management team and ensure that shareholders' interests are well served. Huadong Medicine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Huadong Medicine's outside directors are responsible for providing unbiased perspectives on the board's policies.
Renbo Qiu, CFO Department
Shun Zhou, Deputy Mang
Liang Lv, Chairman GM
Bo Chen, Secretary Board
Hui Wu, Deputy Mang

Huadong Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Huadong Medicine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Huadong Stock

Huadong Medicine financial ratios help investors to determine whether Huadong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Huadong with respect to the benefits of owning Huadong Medicine security.